The impact of patient and public involvement on COVID-19 immunology research: experiences from the UK Coronavirus Immunology Consortium

Abstract Background Patient and Public Involvement (PPI) in clinical trial research is recognised as relevant but the active involvement of patients and the public in basic science or laboratory-based research is seen as more challenging and not often reported. PPI within the UK Coronavirus Immunolo...

Full description

Bibliographic Details
Main Authors: Erika Neves Aquino, Paul Moss, Mo Hafeez, Robert Jasper, Tony Kelly, Lynn Laidlaw, Vivienne Wilkes
Format: Article
Language:English
Published: BMC 2023-05-01
Series:Research Involvement and Engagement
Subjects:
Online Access:https://doi.org/10.1186/s40900-023-00446-1
_version_ 1797817694254268416
author Erika Neves Aquino
Paul Moss
Mo Hafeez
Robert Jasper
Tony Kelly
Lynn Laidlaw
Vivienne Wilkes
author_facet Erika Neves Aquino
Paul Moss
Mo Hafeez
Robert Jasper
Tony Kelly
Lynn Laidlaw
Vivienne Wilkes
author_sort Erika Neves Aquino
collection DOAJ
description Abstract Background Patient and Public Involvement (PPI) in clinical trial research is recognised as relevant but the active involvement of patients and the public in basic science or laboratory-based research is seen as more challenging and not often reported. PPI within the UK Coronavirus Immunology Consortium (UK-CIC), a translational research project aimed at tackling some of the key questions about the immune system’s response to SARS-CoV-2, is an example of overcoming negative perceptions and obstacles. Given the widespread impact of COVID-19, it was important to consider the impact of UK-CIC research on patients and the public throughout, and the PPI panel were an integral part of the consortium. Findings Building in funding for a PPI panel to value involvement and ensuring effective expert administrative support and management of PPI were crucial to success. Facilitating relationships and quality interactions between public contributors and researchers required time and commitment to the project from all parties. Through creating a platform and open space to explore diverse views and a wide range of perspectives, PPI was able to influence researchers’ ways of thinking about their research and impact future research questions about COVID-19 immunology. Moreover, there was long-term impact from the involvement of the PPI panel in COVID-19 research and their value was reflected in invitations to contribute to additional immunology projects. Conclusion The ability to conduct meaningful PPI with basic immunology research has been shown possible through the UK-CIC in the context of the fast-moving COVID-19 pandemic. The UK-CIC project has laid the foundations for PPI in immunology and this should now be built upon for the advantage of future basic scientific research; PPI can impact greatly on laboratory-based research when given the opportunity to do so.
first_indexed 2024-03-13T08:57:13Z
format Article
id doaj.art-3ebf1a8182ea458aa57c988980d0cbfd
institution Directory Open Access Journal
issn 2056-7529
language English
last_indexed 2024-03-13T08:57:13Z
publishDate 2023-05-01
publisher BMC
record_format Article
series Research Involvement and Engagement
spelling doaj.art-3ebf1a8182ea458aa57c988980d0cbfd2023-05-28T11:30:49ZengBMCResearch Involvement and Engagement2056-75292023-05-019111310.1186/s40900-023-00446-1The impact of patient and public involvement on COVID-19 immunology research: experiences from the UK Coronavirus Immunology ConsortiumErika Neves Aquino0Paul Moss1Mo HafeezRobert JasperTony KellyLynn LaidlawVivienne WilkesBritish Society for ImmunologyInstitute of Immunology and Immunotherapy, University of BirminghamAbstract Background Patient and Public Involvement (PPI) in clinical trial research is recognised as relevant but the active involvement of patients and the public in basic science or laboratory-based research is seen as more challenging and not often reported. PPI within the UK Coronavirus Immunology Consortium (UK-CIC), a translational research project aimed at tackling some of the key questions about the immune system’s response to SARS-CoV-2, is an example of overcoming negative perceptions and obstacles. Given the widespread impact of COVID-19, it was important to consider the impact of UK-CIC research on patients and the public throughout, and the PPI panel were an integral part of the consortium. Findings Building in funding for a PPI panel to value involvement and ensuring effective expert administrative support and management of PPI were crucial to success. Facilitating relationships and quality interactions between public contributors and researchers required time and commitment to the project from all parties. Through creating a platform and open space to explore diverse views and a wide range of perspectives, PPI was able to influence researchers’ ways of thinking about their research and impact future research questions about COVID-19 immunology. Moreover, there was long-term impact from the involvement of the PPI panel in COVID-19 research and their value was reflected in invitations to contribute to additional immunology projects. Conclusion The ability to conduct meaningful PPI with basic immunology research has been shown possible through the UK-CIC in the context of the fast-moving COVID-19 pandemic. The UK-CIC project has laid the foundations for PPI in immunology and this should now be built upon for the advantage of future basic scientific research; PPI can impact greatly on laboratory-based research when given the opportunity to do so.https://doi.org/10.1186/s40900-023-00446-1ImmunologyCOVID-19PPIPatient and public involvementPublic contributorsBasic science
spellingShingle Erika Neves Aquino
Paul Moss
Mo Hafeez
Robert Jasper
Tony Kelly
Lynn Laidlaw
Vivienne Wilkes
The impact of patient and public involvement on COVID-19 immunology research: experiences from the UK Coronavirus Immunology Consortium
Research Involvement and Engagement
Immunology
COVID-19
PPI
Patient and public involvement
Public contributors
Basic science
title The impact of patient and public involvement on COVID-19 immunology research: experiences from the UK Coronavirus Immunology Consortium
title_full The impact of patient and public involvement on COVID-19 immunology research: experiences from the UK Coronavirus Immunology Consortium
title_fullStr The impact of patient and public involvement on COVID-19 immunology research: experiences from the UK Coronavirus Immunology Consortium
title_full_unstemmed The impact of patient and public involvement on COVID-19 immunology research: experiences from the UK Coronavirus Immunology Consortium
title_short The impact of patient and public involvement on COVID-19 immunology research: experiences from the UK Coronavirus Immunology Consortium
title_sort impact of patient and public involvement on covid 19 immunology research experiences from the uk coronavirus immunology consortium
topic Immunology
COVID-19
PPI
Patient and public involvement
Public contributors
Basic science
url https://doi.org/10.1186/s40900-023-00446-1
work_keys_str_mv AT erikanevesaquino theimpactofpatientandpublicinvolvementoncovid19immunologyresearchexperiencesfromtheukcoronavirusimmunologyconsortium
AT paulmoss theimpactofpatientandpublicinvolvementoncovid19immunologyresearchexperiencesfromtheukcoronavirusimmunologyconsortium
AT mohafeez theimpactofpatientandpublicinvolvementoncovid19immunologyresearchexperiencesfromtheukcoronavirusimmunologyconsortium
AT robertjasper theimpactofpatientandpublicinvolvementoncovid19immunologyresearchexperiencesfromtheukcoronavirusimmunologyconsortium
AT tonykelly theimpactofpatientandpublicinvolvementoncovid19immunologyresearchexperiencesfromtheukcoronavirusimmunologyconsortium
AT lynnlaidlaw theimpactofpatientandpublicinvolvementoncovid19immunologyresearchexperiencesfromtheukcoronavirusimmunologyconsortium
AT viviennewilkes theimpactofpatientandpublicinvolvementoncovid19immunologyresearchexperiencesfromtheukcoronavirusimmunologyconsortium
AT erikanevesaquino impactofpatientandpublicinvolvementoncovid19immunologyresearchexperiencesfromtheukcoronavirusimmunologyconsortium
AT paulmoss impactofpatientandpublicinvolvementoncovid19immunologyresearchexperiencesfromtheukcoronavirusimmunologyconsortium
AT mohafeez impactofpatientandpublicinvolvementoncovid19immunologyresearchexperiencesfromtheukcoronavirusimmunologyconsortium
AT robertjasper impactofpatientandpublicinvolvementoncovid19immunologyresearchexperiencesfromtheukcoronavirusimmunologyconsortium
AT tonykelly impactofpatientandpublicinvolvementoncovid19immunologyresearchexperiencesfromtheukcoronavirusimmunologyconsortium
AT lynnlaidlaw impactofpatientandpublicinvolvementoncovid19immunologyresearchexperiencesfromtheukcoronavirusimmunologyconsortium
AT viviennewilkes impactofpatientandpublicinvolvementoncovid19immunologyresearchexperiencesfromtheukcoronavirusimmunologyconsortium